Skip to main content

Table 4 Length of stay by SARS-CoV-2, testing, and non-SARS-CoV-2 pathogen status

From: A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Admission site and pathogen status Not tested for SARS-CoV-2 Tested for SARS-CoV-2
SARS-CoV-2 negative SARS-CoV-2 positive
n LOS n LOS n LOS
Hospitala 449,339 4.2 (8.0) [2] 124,618 5.1 (8.9) [3] 17,003 8.6 (11.4) [6]
 Positive for non-SARS-CoV-2 pathogen 52,418 7.1 (11.0) [4] 24,442 8.2 (11.5) [5] 3483 13.7 (15.7) [9]
 Negative for non-SARS-CoV-2 pathogen 396,921 3.9 (7.4) [2] 100,176 4.3 (7.9) [3] 13,566 7.3 (9.6) [5]
 Multiple non-SARS-CoV-2 pathogens 17,871 8.7 (13.2) [5] 9101 10.2 (14.6) [6] 1192 17.5 (16.1) [14]
ICUa 47,629 3.6 (5.9) [2] 21,060 3.8 (6.2) [2] 4076 7.8 (8.5) [5]
  1. Data are expressed as mean (standard deviation) [median] days. P < 0.05 across groups for all outcomes
  2. Note: ICU intensive care unit, LOS length of stay
  3. aOverall hospital and ICU LOS include patients with no specimen collected